Caris Life Sciences announced positive results for its multi-cancer detection study. On March 31, the company finalized the Achieve 1 study, validating the accuracy of its Caris Detect early detection test. The results demonstrated the superiority of Whole Genome Sequencing (WGS) over methylation-based approaches in sensitivity and specificity. This milestone is a key step toward the future launch of the Caris Detect™ test.
